Lung Cancer
News and reporting on lung cancer.
BioAffinity Technologies Acquires Lab Assets of Precision Pathology Services for $3.5M
BioAffinity said the deal will help it accelerate market uptake of its CyPath Lung test, which uses flow cytometry and AI for the early detection of lung cancer.
Local Coverage Determinations Roundup: Scipher Medicine, Veracyte, Sonic Healthcare USA
A roundup of local coverage determinations from Medicare administrative contractors.
Guardant Health Receives Guardant360 CDx Regulatory Approval in Japan for HER2 Lung Cancer Treatment
Patients who test positive for a HER2 mutation and have seen their disease progress after chemotherapy can now be treated with Daiichi Sankyo's Enhertu.
The method, called GEMINI, improved detection of both overall cancer and the earliest-stage cancers when added to the firm's existing platform.
The preprint raised concerns about the findings of a 2020 cancer microbiome study that spurred the development of a microbiome-based liquid biopsy test for cancer.